Hayward Jessica H, Ray Kimberly M, Wisner Dorota J, Joe Bonnie N
Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA.
Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA.
Clin Imaging. 2016 Sep-Oct;40(5):1034-9. doi: 10.1016/j.clinimag.2016.06.005. Epub 2016 Jun 16.
To evaluate outcomes of benign concordant magnetic resonance imaging (MRI)-guided breast biopsy.
We retrospectively reviewed 611 consecutive MRI-guided breast core biopsies at our institution from 2005 to 2012. Benign concordant cases with MRI follow-up constituted the study group. Lesion appearance on follow-up MRI was assessed and the false-negative rate was calculated.
Eighty-four lesions in 68 women underwent benign concordant MRI-guided biopsy with subsequent MRI follow-up. Mean time to first follow-up MRI was 10.5 months. Two false negatives were identified on follow-up at 8 and 26 months.
We report a false-negative rate of MRI-guided breast biopsy of 2.4%.
评估良性一致性磁共振成像（MRI）引导下乳腺活检的结果。
我们回顾性分析了2005年至2012年在我院连续进行的611例MRI引导下乳腺粗针活检。MRI随访的良性一致性病例构成研究组。评估随访MRI上病变的表现并计算假阴性率。
68名女性的84个病变接受了良性一致性MRI引导下活检并随后进行了MRI随访。首次随访MRI的平均时间为10.5个月。在8个月和26个月的随访中发现了2例假阴性。
我们报告MRI引导下乳腺活检的假阴性率为2.4%。
